Key result
SAMe-TT2R2 score-guided educational-behavioral intervention plus usual care did not significantly improve time in therapeutic range at 6 and 12 months compared with usual care in Thai AF patients.
Why the study?
Does the SAMe-TT2R2 score effectively predict warfarin anticoagulation quality (time in therapeutic range) and guide clinical management in non-Caucasian patients with atrial fibrillation?
Does the SAMe-TT2R2 score effectively predict warfarin anticoagulation quality (time in therapeutic range) and guide clinical management in non-Caucasian patients with atrial fibrillation?
Answers are grounded in this paper and cite their sources.
This editorial highlights the limitations of the standard SAMe-TT2R2 score in Asian populations and suggests integrating pharmacogenomics (CYP2C9 and VKORC1) and mobile health technologies to improve individualized anticoagulation management in atrial fibrillation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yundai Chen (2024) conducted an editorial in Atrial fibrillation. SAMe-TT2R2 score-guided educational-behavioral intervention plus usual care vs. Usual care alone was evaluated on Time in therapeutic range (TTR) at 6 and 12 months. SAMe-TT2R2 score-guided educational-behavioral intervention plus usual care did not significantly improve time in therapeutic range at 6 and 12 months compared with usual care in Thai AF patients.
Synapse has enriched 10 related papers. Consider them for comparative context: